New search Show text from Guidelines
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSL04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AG Monoclonal antibodies
| ATC code | Name | DDD | U | Adm.R | Note |
| L04AG01 | muromonab-CD3 | 5 | mg | P | |
| L04AG02 | efalizumab | 10 | mg | P | |
| L04AG03 | natalizumab | 10 | mg | P | |
| L04AG04 | belimumab | 25 | mg | P | |
| L04AG05 | vedolizumab | 5.4 | mg | P | |
| L04AG06 | alemtuzumab | 0.13 | mg | P | |
| L04AG07 | begelomab | ||||
| L04AG08 | ocrelizumab | 3.29 | mg | P | |
| L04AG09 | emapalumab | ||||
| L04AG10 | inebilizumab | ||||
| L04AG11 | anifrolumab | 10.7 | mg | P | |
| L04AG12 | ofatumumab | 0.67 | mg | P | |
| L04AG13 | teprotumumab | ||||
| L04AG14 | ublituximab | ||||
| L04AG15 | divozilimab | ||||
| L04AG16 | rozanolixizumab |
Last updated: 2024-01-26